MESO Competitors & Alternatives
Compare Mesoblast Ltd with similar stocks in the same industry
Biotechnology
MESO
Main Stock$12.79
Tradestie Score
51
Market Cap
$2.08B
Revenue Growth
3.9%
Analyst Upside
+189.4%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLDX
Celldex Therapeutics, Inc
|
$29.25
|
$1.68B | - | 61 | Compare |
|
MNKD
Mannkind Corporation
|
$3.09
|
$1.65B | - | 57 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$39.61
|
$1.63B | - | 60 | Compare |
|
BHVN
Biohaven Ltd.
|
$15.34
|
$1.57B | - | 67 | Compare |
|
VCEL
Vericel Corporation
|
$40.98
|
$1.56B | 86.3 | 57 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$77.16
|
$1.55B | - | 59 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$39.21
|
$1.55B | 12.5 | 67 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$30.27
|
$1.55B | - | 62 | Compare |
|
NVAX
Novavax Inc
|
$10.66
|
$1.54B | - | 45 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$16.95
|
$1.50B | 7.3 | 55 | Compare |
More MESO Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2836)
223 stocks in this industry